CELZ: Creative Medical Technology P/S multiplikatori

Creative Medical Technology (CELZ) rahbariyati klinik sinovlar xarajatlari tufayli likvidlik tanqisligiga duch kelmoqda. Tarixiy P/S darajasi ushbu bosimning oqibatlarini ko'rsatadi, bunda 849.40 belgisi joriy holatni anglatadi. Creative Medical Technology (CELZ) erkaklar bepushtligiga qarshi kurashish uchun noyob AmnioStem hujayraviy mahsulotlarini yaratish orqali urologiya patentlarini monetizatsiya qilmoqda, bu esa kompaniyaga regenerativ tibbiyotdagi bo'sh nishalarni egallash imkonini beradi.

CELZ - Creative Medical Technology Holdings Inc. P/S multiplikatori 04.07.2022 - 09.05.2026 oraligʻida

Creative Medical Technology (CELZ) kompaniyasining tahliliy kesimlari

- joriy kotirovkalar va o'rtacha qiymat prognozi:

Birja narxi creativemedicaltechnology.com|CELZ - Tahlilchilar konsensus prognozi

- bozor kapitallashuvi haqida ma'lumot:

Bozor kapitallashuvi Creative Medical Technology Holdings Inc.|CELZ - Kompaniyani butunlay sotib olishdagi haqiqiy narx

- balans bo'yicha xususiy kapital ma'lumotlari:

Aksiyaning balans narxi Creative Medical Technology|CELZ - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi creativemedicaltechnology.com|CELZ - Kompaniyaning yakuniy aktivlari

- biznesning qarz tarkibi va likvidligi tafsilotlari:

Qarzning xususiy kapitalga nisbati Creative Medical Technology|CELZ - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati creativemedicaltechnology.com|CELZ - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Creative Medical Technology Holdings Inc.|CELZ - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli majburiyatlari Creative Medical Technology|Shoshilinch likvidlik creativemedicaltechnology.com

- foyda va bozor koeffitsiyentlari statistikasi:

CELZ - Sof foyda|Sof foyda prognozi Creative Medical Technology|CELZ - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati creativemedicaltechnology.com|CELZ - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Creative Medical Technology Holdings Inc.|CELZ - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Creative Medical Technology|CELZ - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi creativemedicaltechnology.com|CELZ - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Creative Medical Technology

- emitentning tushumi va sotuvlari tafsilotlari:

CELZ - Kompaniya savdosi|Kompaniyaning prognoz qilingan daromad hajmi creativemedicaltechnology.com|CELZ - P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Creative Medical Technology Holdings Inc.

Kompaniyaning jamlanma tahliliyoti:Creative Medical Technology Holdings, Inc., CELZ

Creative Medical Technology Holdings Inc. tovar namunasi

P/S koeffitsiyenti bozor kapitalizatsiyasining umumiy savdoga nisbati sifatida hisoblanadi va investorlar nazarida bir dollar daromadning qiymatini o'lchaydi. StemSpine va Stem cell therapy sektorlarida begubor imidjga ega bo'lgan Creative Medical Technology (CELZ) uchun median P/S koeffitsiyenti bozor shovqinlari uchun filtr vazifasini o'taydi, bu esa aktivlarning adolatli qiymatini biznesning haqiqiy daromadlariga nisbatan aniqlash imkonini beradi.

Creative Medical Technology raqobatchilari

MESO - Sotuvga nisbatan narx|P/S multiplikatori LCTX (Lineage Cell Therapeutics, Inc.)|P/S multiplikatori Surrozen Inc SRZN|CCEL: Kapitalizatsiyaning daromadga nisbati|FibroBiologics, Inc. - Kapitalizatsiyaning sotish hajmiga nisbati|LGVN: P/S multiplikatori|BRTX - Narx/daromad koeffitsiyenti